More and more major medical companies such as Medtronic and Novo Nordisk are collaborating in allowing their diabetes supplies to connect with one another, making tracking and sharing data easier.
Medtronic recently announced a partnership with Novo Nordisk for their GCMs and smart insulin pens to be compatible. This comes at the same time as a similar deal between Abbott and Sanofi to integrate glucose sensing and insulin delivery devices.
With this new deal, Novo Nordisk’s pens will now collaborate with all major CGM makers.
Benefits of the new partnership
This development will make it easier to track and share blood glucose levels and insulin dosages. Managing these values closely and sharing them with a medical team are crucial to achieving glycemic control and warding off serious diabetes complications.
New Novo Nordisk NovoPen 6 and NovoPen Echo Plus will be available in 2020. At that time, they will be compatible with Apple and Android devices, plus Medtronic’s updated Guardian Connect CGM.
What are smart insulin pens?
Smart insulin pens make the process of managing your diabetes easier. These Bluetooth-enabled insulin pens combine the features of being an injector pen and bolus adviser, plus connection to smartphone apps. Smart insulin pens record the date and time of insulin injections. The pens are reusable, and use cartridges of insulin that are inserted into the pen. Some even offer half-unit increments so that you can get just the right dose.
What are CGMs?
A continuous glucose monitor replaces finger pricks as a way to constantly monitor blood sugar levels throughout the day and night. The device attaches to your body and takes regular blood glucose readings via a wire inserted under the skin. It then sends that information to a smartphone or receiver so that the data can be stored and tracked.
Readings are done every 5 minutes, for up to 288 readings per day. The CGM will sound an alarm if blood sugar drops too low, or if it senses a high forthcoming. Some even sync with an iPhone so you can ask Siri what your blood sugar levels are while you are driving.
With these new collaborations, diabetes management should be smoother and take less time, plus allow doctors to easily access the health data they need.